Women who do not need pain relief during childbirth may be carriers of a key genetic variant that acts a natural epidural, say scientists at the University of Cambridge. In a study published today in the journal Cell Reports, the researchers explain how the variant limits the ability of nerve cells to send pain signals to the brain.
Cambridge researchers have shown how rapid genome sequencing of virus samples and enhanced testing of hospital staff can help to identify clusters of healthcare-associated COVID-19 infections.
Recruitment has begun at three leading Cambridgeshire NHS Trusts for volunteers to take part in the nationwide COVID-19 vaccine trial.
A new trial to prevent organ failure and death in COVID-19 patients has been launched led by clinicians and scientists in Cambridge and London.
Hospital staff may be carrying SARS-CoV-2, the coronavirus that causes COVID-19 disease, without realising they are infected, according to a study by researchers at the University of Cambridge.
It’s been decades since Professor Paul Fletcher last donned scrubs, but he now finds himself helping treat psychiatric patients, sometimes in full protective gear, and learning that the best strategy is to “shut up and listen” to his colleagues.
A team at the University of Cambridge has shown how, in osteoarthritis patients, the viscous lubricant that ordinarily allows our joints to move smoothly triggers a pain response from nerve cells similar to that caused by chilli peppers.
A new tool to predict an individual’s prognosis following a prostate cancer diagnosis could help prevent unnecessary treatment and related side effects, say researchers at the University of Cambridge.
The Secretary of State for Health and Social Care, Matt Hancock, has announced up to £100 million of public capital for an innovative children’s hospital for the east of England. This will be a new facility that is purpose-built to meet the needs of the region’s youngest patients, integrating mental and physical health and combining the highest quality services with world class science and research.
An international trial to test whether an artificial pancreas can help young children manage their type 1 diabetes will begin next year, thanks to a major grant awarded by the European Commission.
© 2025 University of Cambridge